- Home
- BTOG vs ISPC Comparison
BTOG vs ISPC Comparison
Compare BTOG & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BTOG | ISPC |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Precision Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4M | 3.8M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BTOG | ISPC |
|---|---|---|
| Price | $0.81 | $2.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 194.9K | 52.0K |
| Earning Date | 06-26-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 87.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,928,998.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.08 | $0.10 |
| 52 Week High | $5.96 | $6.77 |
Technical Indicators
Market Signals| Indicator | BTOG | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 36.86 | 52.55 |
| Support Level | $0.62 | $0.25 |
| Resistance Level | $0.94 | $4.49 |
| Average True Range (ATR) | 0.08 | 0.18 |
| MACD | 0.03 | 0.06 |
| Stochastic Oscillator | 66.66 | 86.89 |
Price Performance
Historical ComparisonAbout BTOG Bit Origin Limited
Bit Origin Ltd is seeking opportunities in deploying new technologies, crypto asset mining and blockchain technologies in Singapore. The company has focused on building the Bitcoin mining ecosystem through incubations, strategic investments, and acquisitions. It derives all of its revenue from Bitcoin mining.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.